Abstract:across the family. Biological responses mediated by TNF␣ range from gene induction events that mediate inflammatory responses to cellular apoptosis and necro-which may limit their ability to activate lymphocytes (Wang et al., 1999). TNF␣ binds to two distinct, type I membrane receptors One of the hallmarks of the immune system is the con-on the cell surface, TNFR-1 (p55/p60) and TNFR-2 (p75/ stant expansion and contraction of different cell popula-p80), while Fas-L binds to another TNFR-like molecule tions as a result of homeostatic immune regulation. called Fas/CD95/Apo-1. The extracellular domains Expansion and proliferation of T and B lymphocytes and (ECDs) of the TNFRs contain one to six characteristic antigen-presenting cells (APCs) in the midst of antigenic cysteine-rich domains (CRDs). They can be further di-challenges is countered by contraction of the same pop-vided into two subgroups based on the structure of ulations of cells through apoptosis as the immune reac-their cytoplasmic tails. TNFR-1 and Fas/CD95/Apo-1 are tion attenuates. Hence, apoptosis or programmed cell representatives of a subset of TNFR-like receptors that death is at the heart of homeostatic balance within the share a homologous motif in the cytoplasmic tail called immune system. Members of the tumor necrosis factor the " death domain " (DD). Upon activation, the DD serves (TNF) receptor superfamily play critical roles in lympho-as a docking site for DD-containing adaptor proteins cyte apoptosis during immune regulation. We will focus such as TRADD (for TNFR-1) and FADD (for Fas) through our discussion on how structural features of TNF recep-homotypic DD interactions. Ultimately, the recruitment tor (TNFR)-like receptors affect the regulation of T cell of caspase-8 or-10 via FADD initiates the enzymatic homeostasis. cascade of apoptosis. Consistently, FADD or caspase-8 deficiencies lead to resistance of apoptosis induction by Fas and TNFR-1. For the TNFR-1 signaling complex, Apoptosis in Central and Peripheral Tolerance In the thymus, the developing T cell repertoire under-receptor activation can also lead to the recruitment of RIP and TRAF2 through TRADD (Figure 1B). RIP is a goes positive and negative selection to achieve effectiveness against foreign antigenic challenge and to DD-containing kinase that is crucial for NF-␬B activation while TRAF2 activates the MAP kinases. Both RIP or minimize the possibility of reaction to self-antigens. Evidence indicates that most thymocytes do not employ TRAF2 deficiencies result in hypersensitivity to TNF␣-induced cytotoxicity (reviewed in Wallach et al., 1999). TNFR-like receptors in death induction. Mature T cells are subject to further …

Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.

The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors

TNF receptors: Structure-function relationships and therapeutic targeting strategies

Receptor Specificity Engineering of TNF Superfamily Ligands

Manipulation of Receptor Oligomerization As a Strategy to Inhibit Signaling by TNF Superfamily Members

Expression and Purification of a Natural N-Terminal Pre-ligand Assembly Domain of Tumor Necrosis Factor Receptor 1 (TNFR1 PLAD) and Preliminary Activity Determination

Editorial: Targeting TNF/TNFR signaling pathways.

TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity

Signaling by the TNF Receptor Minireview Superfamily and T Cell Homeostasis

Lipopolysaccharide Signal Transduction, Regulation of Tumor Necrosis Factor Biosynthesis, and Signaling by Tumor Necrosis Factor Itself

Tnf-R1 Signaling: A Beautiful Pathway

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling

Trivalent Soluble TNF Receptor, a Potent TNF-α Antagonist for the Treatment Collagen-Induced Arthritis.

Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer

Differential Regulation Of The Expression Of Cd95 Ligand, Receptor Activator Of Nuclear Factor-Kappa B Ligand (Rankl), Tnf-Related Apoptosis-Inducing Ligand (Trail), And Tnf-Alpha During T Cell Activation

Structural principles of tumor necrosis factor superfamily signaling

Mechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 Assembly.

Selective Targeting of TNF Receptors as a Novel Therapeutic Approach

Establishing the Structural Rules for Ligand Recognition, Signaling and Assembly in Innate Immune Receptors

Coarse Grained Molecular Dynamic Simulations for the Study of TNF Receptor Family Members' Transmembrane Organization

Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation